2m 2m 2m 2m 2m 2m 2m
CURIS (CRIS)
NASDAQ
$0.37+$0.01 (+2.85%)
Price as of Jun 23, 2026 7:59 PM EDT- $16.7MMarket Cap
- -83.48%1-Year Change
- BiotechnologyIndustry
CURIS (CRIS)
$0.37+$0.01 (+2.85%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.4M -13.43% | 10.9M +8.83% | 10.0M -1.37% | 10.2M -4.57% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 9.4M -13.43% | 10.9M +8.83% | 10.0M -1.37% | 10.2M -4.57% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -28.3M -26.73% | -38.6M -2.36% | -39.5M -8.74% | -43.3M +24.06% | |
Depreciation and Amortization Expense | 169,000 -16.75% | 203,000 -20.39% | 255,000 +9.44% | 233,000 +47.47% | |
Total Operating Expenses | 42.3M -23.63% | 55.5M -4.98% | 58.4M -7.64% | 63.2M +19.86% | |
Operating Profit | -5.7M -87.17% | -44.5M -7.84% | -48.3M -8.84% | -53.0M +26.04% | |
Interest Income | 316,000 -82.13% | 1.8M -39.82% | 2.9M +162.56% | 1.1M +430.33% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 316,000 -82.13% | 1.8M -39.82% | 2.9M +162.56% | 1.1M +430.33% | |
Total Nonoperating Income and Expense | -1.9M -262.10% | 1.2M +25.46% | 919,000 +125.16% | -3.7M +8.34% | |
Income before Taxes | -5.7M -87.17% | -44.5M -7.84% | -48.3M -8.84% | -53.0M +26.04% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -7.6M -82.53% | -43.4M -8.49% | -47.4M -16.34% | -56.7M +24.73% | |
Net Income from Continuing Operations Applicable to Common | -7.6M -82.53% | -43.4M -8.49% | -47.4M -16.34% | -56.7M +24.73% | |
Basic EPS and Net Income | -0.58 -91.57% | -6.88 -23.21% | -8.96 -1,568.85% | 0.61 +222.00% | |
Diluted EPS and Net Income | -0.58 -91.57% | -6.88 -23.21% | -8.96 -1,568.85% | 0.61 +222.00% | |
Basic Weighted Average Shares | 13.2M +108.74% | 6.3M +19.14% | 5.3M -94.33% | 93.4M +1.99% | |
Diluted Weighted Average Shares | 13.2M +108.74% | 6.3M +19.14% | 5.3M -94.33% | 93.4M +1.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 5.1M -74.69% | 20.0M -25.05% | 26.7M +35.73% | 19.7M -50.87% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 29.7M -55.05% | 66.0M -13.06% | |
Cash and Cash Equivalents and Short-Term Investments | 5.1M -74.69% | 20.0M -64.50% | 56.3M -34.21% | 85.6M -26.11% | |
Total Current Assets | 6.9M -73.79% | 26.4M -56.68% | 60.9M -33.88% | 92.1M -24.72% | |
Accumulated Depreciation | 851,000 -15.99% | 1.0M -49.12% | 2.0M -18.97% | 2.5M +10.43% | |
Property and Plant and Equipment and Net | 62,000 -73.16% | 231,000 -46.77% | 434,000 -37.01% | 689,000 +36.44% | |
Total Long-Term Assets | 1.6M -19.74% | 2.0M -41.63% | 3.4M +66.07% | 2.0M N/A | |
Total Assets | 20.0M -51.62% | 41.3M -46.60% | 77.3M -29.00% | 108.8M -32.93% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 7.6M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 14.1M -26.02% | 19.0M +40.76% | 13.5M +34.99% | 10.0M -25.49% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 900,000 0.00% | |
Total Long-Term Liabilities | 428,000 -73.55% | 1.6M +8.66% | 1.5M -46.82% | 2.8M N/A | |
Total Liabilities | 14.5M -69.31% | 47.3M -17.96% | 57.6M -7.52% | 62.3M -12.99% | |
Retained Earnings | -1.2B +0.61% | -1.2B +3.63% | -1.2B +4.13% | -1.1B +5.19% | |
Total Stockholders Equity | 5.5M +191.06% | -6.0M -130.49% | 19.7M -57.75% | 46.6M -48.68% | |
Total Shares Outstanding | 12.9M +52.32% | 8.5M +44.01% | 5.9M -93.90% | 96.6M +5.41% | |
Cash Flow | |||||
Cash from Operating Activities | -27.2M -31.25% | -39.6M +2.94% | -38.4M -29.27% | -54.3M +44.44% | |
Capital Expenditures | N/A N/A | N/A N/A | 0 -100.00% | 416,000 N/A | |
Cash from Investing Activities | 2.5M -91.51% | 29.4M -22.08% | 37.8M +14.42% | 33.0M +168.95% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 9.8M +184.11% | 3.4M -54.66% | 7.6M +774.28% | 867,000 +120.78% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -60.50% -85.18% | -408.34% -15.32% | -482.21% -7.58% | -521.75% +32.08% | |
Return on Assets | -24.77% -66.17% | -73.20% +43.68% | -50.95% +21.88% | -41.80% +68.66% | |
Return on Equity | 2,829.10% +545.73% | -634.71% +343.25% | -143.19% +73.41% | -82.58% +101.17% | |
Revenue Growth | -13.43% -252.11% | 8.83% +745.54% | -1.37% -70.09% | -4.57% +166.39% | |
Current Ratio | 0.49 -64.57% | 1.39 -69.23% | 4.51 -51.02% | 9.20 +1.02% | |
Cash Ratio | 0.36 -65.79% | 1.05 -46.76% | 1.97 +0.55% | 1.96 -34.07% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow